Cargando…

Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration‐resistant prostate cancer

BACKGROUND: Elevated serum carcinoembryonic antigen (CEA) is used to identify “treatment emergent” forms of castration‐resistant prostate cancer (CRPC) such as aggressive variant prostate cancer (AVPC). However, its individual utility as a prognostic marker and the genetic alterations associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bray, Alexander W., Duan, Rong, Malalur, Pannaga, Drusbosky, Leylah M., Gourdin, Theodore S., Hill, Elizabeth G., Lilly, Michael B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388585/ https://www.ncbi.nlm.nih.gov/pubmed/35766303 http://dx.doi.org/10.1002/pros.24400

Ejemplares similares

Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case Series
por: Ravindranathan, Deepak, et al.
Publicado: (2021)

Neurotoxic manifestations of high-dose intrathecal gadolinium administration for CT myelogram
por: Malalur, Pannaga, et al.
Publicado: (2020)

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes
por: Drusbosky, Leylah M., et al.
Publicado: (2017)

Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes
por: Drusbosky, Leylah M., et al.
Publicado: (2020)

Atypical Lung Carcinoid With EML4/ALK Fusion Detected With Circulating Tumor DNA
por: Gococo-Benore, Denise A, et al.
Publicado: (2022)

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer
por: Gourdin, Theodore, et al.
Publicado: (2018)

Therapeutic strategies in RET gene rearranged non-small cell lung cancer
por: Drusbosky, Leylah M., et al.
Publicado: (2021)

Therapeutic strategies in METex14 skipping mutated non-small cell lung cancer
por: Drusbosky, Leylah M., et al.
Publicado: (2021)

Cancer survivorship in hematologic malignancies: Lifestyle changes after diagnosis
por: Malalur, Pannaga, et al.
Publicado: (2021)

Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study
por: Drusbosky, Leylah, et al.
Publicado: (2020)

CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA
por: Cai, Zerong, et al.
Publicado: (2020)

Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
por: Katano, Atsuto, et al.
Publicado: (2021)

Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients
por: Cho, Won Jin, et al.
Publicado: (2016)

Elevated CEA is associated with worse survival in recurrent rectal cancer
por: Cho, Won Kyung, et al.
Publicado: (2017)

Three cases of brain metastasis from castration‐resistant prostate cancer
por: Shida, Yohei, et al.
Publicado: (2019)

Test Results of the Third LHC Main Quadrupole Magnet Prototype at CEA/Saclay
por: Derégel, J, et al.
Publicado: (2002)

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Li, Qiuhui, et al.
Publicado: (2018)

Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer
por: Lin, Hui-Ming, et al.
Publicado: (2021)

Gastric duplication cyst with elevated CEA level: a case report
por: Tessely, Héloïse, et al.
Publicado: (2018)

Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients
por: Isebia, Khrystany T., et al.
Publicado: (2022)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Denosumab: Delay of bone metastasis in men with nonmetastatic castrate-resistant prostate cancer
por: Manger, Jules P., et al.
Publicado: (2012)

Unusual presentation of castrate-resistant prostate cancer with urethral and inguinal nodal metastasis
por: Jindal, Tarun, et al.
Publicado: (2021)

Castration-resistant prostate cancer with metastasis to external auditory canal – Case report
por: Akagi, Naoki, et al.
Publicado: (2022)

Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition
por: Drusbosky, Leylah, et al.
Publicado: (2015)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
por: Lin, H-M, et al.
Publicado: (2014)

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer
por: Lin, Hui-Ming, et al.
Publicado: (2017)

Patterns of recurrence and modes of progression after metastasis-directed therapy in oligometastatic castration-sensitive prostate cancer
por: Deek, Matthew P., et al.
Publicado: (2020)

A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer
por: Zhuang, Eric, et al.
Publicado: (2021)

CEA solenoide
por: Sylvie Prodon
Publicado: (2003)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer
por: Wang, Xiaobing, et al.
Publicado: (2017)

Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer
por: Palmer, Hannah, et al.
Publicado: (2022)

SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer
por: Xu, Zhenzhou, et al.
Publicado: (2021)

Intra-Parenchymal Cerebellar Metastasis—A Rare Presentation of Castration-Resistant Prostate Cancer
por: Ibrahim, Sufyan, et al.
Publicado: (2022)

Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer
por: Peter, Madonna R., et al.
Publicado: (2021)

Castration for Hypertrophy of the Prostate Gland
Publicado: (1895)

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
por: Magbanua, Mark Jesus M, et al.
Publicado: (2012)

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer
por: Mostaghel, Elahe A., et al.
Publicado: (2021)

Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer
por: Francini, Edoardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t4m8opdr4mgp3mkq2humlmu97e